Skip to main content

Market Overview

Why This UnitedHealth Analyst Sees Upside Ahead Following Q2 Earnings

Share:
Why This UnitedHealth Analyst Sees Upside Ahead Following Q2 Earnings

Shares of UnitedHealth Group Inc (NYSE: UNH) rallied 5.38% on Friday after the health insurer reported a second-quarter earnings beat and hiked its full-year guidance.

The Numbers: On Thursday, UnitedHealth reported second-quarter adjusted EPS of $5.57 on revenue of $80.3 billion. Both numbers topped consensus analyst estimates of $5.21 and $79.7 billion, respectively. Revenue was up 13% from a year ago.

Related Link: Why Novavax Shares Are Plunging Today Despite Much Awaited FDA Emergency Nod?

UnitedHealth reported $45.1 billion in revenue from its Optum segment, up 18% year-over-year. It also reported its medical care ratio (MLR), the percentage of premiums paid out as medical claims, dropped from 82.8% to 81.5% in the quarter.

Looking ahead, UnitedHealth guided for full-year adjusted EPS of between $21.40 and $21.90, up from its previous target range of between $21.20 and $21.70. Analysts had been expecting $21.69.

Related Link: Quest Diagnostics Unveils Monkeypox Test: What You Need To Know

Analyst Take: Following the report, Bank of America analyst Kevin Fischbeck said the drop in MLR was particularly bullish.

"Overall, the beat and raise is solid and somewhat expected given the depressed utilization and is a positive for the group," Fischbeck said.

He said UnitedHealth's earnings came in above expectations even after accounting for a favorable prior period development. UnitedHealthcare exceeded Bank of America's expectations by 17%, and Fischbeck said Optum continues to outperform.

In addition, he said the fact that UnitedHealth boosted its reserves suggests the updated full-year guidance range may be conservative.

Bank of America has a Buy rating and $632 price target for UnitedHealth.

Benzinga's Take: UnitedHealth's 13% revenue growth is impressive for a company its size, and Optum continues to be the golden goose. UnitedHealth isn't the type of stock that is going to knock your socks off with huge gains, but the company is certainly one of the best defensive blue chip stocks in the health care sector.

Latest Ratings for UNH

DateFirmActionFromTo
Jan 2022SVB LeerinkMaintainsOutperform
Jan 2022BMO CapitalMaintainsMarket Perform
Jan 2022Raymond JamesMaintainsStrong Buy

View More Analyst Ratings for UNH

View the Latest Analyst Ratings

 

Related Articles (UNH)

View Comments and Join the Discussion!

Posted-In: Analyst Color Earnings News Price Target Reiteration Analyst Ratings Movers Trading Ideas

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com